Jörg Mansfeld

Jörg Mansfeld

Auto-generated profile, based on publicly available information

Jörg Mansfeld

Division of Cell and Molecular Biology, The Institute of Cancer Research, London, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Cell
Verified
Journal Article
Closed access
MHMarco Y. Hein
Marco Y. Hein
NHNina C. Hubner
Nina C. Hubner
IPIna Poser
Ina Poser
JCJürgen Cox
Jürgen Cox
NNNagarjuna Nagaraj
Nagarjuna Nagaraj
MMMatthias Mann
Matthias Mann

2 February 2015 in Nature Methods
Verified
Journal Article
Closed access
OOOliver Otto
Oliver Otto
PRPhilipp Rosendahl
Philipp Rosendahl
AMAlexander Mietke
Alexander Mietke
SGStefan Golfier
Stefan Golfier
CHChristoph Herold
Christoph Herold
JGJochen Guck
Jochen Guck

20 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAlexis R. Barr
Alexis R. Barr
SCSamuel Cooper
Samuel Cooper
FHFrank S. Heldt
Frank S. Heldt
FBFrancesca Butera
Francesca Butera
HSHenriette Stoy
Henriette Stoy
CBChris Bakal
Chris Bakal
Following DNA damage caused by exogenous sources, such as ionizing radiation, the tumour suppressor p53 mediates cell cycle arrest via expression of the CDK inhibitor, p21. However, the role of p21 in maintaining genomic stability in the absence of exogenous DNA-damaging agents is unclear. Here, using live single-cell measurements of p21 protein in proliferating cultures, we show that naturally occurring DNA damage incurred over S-phase causes p53-dependent accumulation of p21 during mother G2- and daughter G1-phases. High p21 levels mediate G1 arrest via CDK inhibition, yet lower levels have no impact on G1 progression, and the ubiquitin ligases CRL4Cdt2 and SCFSkp2 couple to degrade p21 prior to the G1/S transition. Mathematical modelling reveals that a bistable switch, created by CRL4Cdt2, promotes irreversible S-phase entry by keeping p21 levels low, preventing premature S-phase exit upon DNA damage. Thus, we characterize how p21 regulates the proliferation-quiescence decision to maintain genomic stability.

1 April 2006 in Molecular Cell
Verified
Journal Article
Closed access
JMJörg Mansfeld
Jörg Mansfeld
SGStephan Güttinger
Stephan Güttinger
LHLisa A. Hawryluk-Gara
Lisa A. Hawryluk-Gara
NPNelly Panté
Nelly Panté
MMMoritz Mall
Moritz Mall
Wolfram AntoninWolfram Antonin
Wolfram Antonin

11 October 2009 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
MGMathew J. Garnett
Mathew J. Garnett
JMJörg Mansfeld
Jörg Mansfeld
CGColin Godwin
Colin Godwin
TMTakahiro Matsusaka
Takahiro Matsusaka
JWJiahua Wu
Jiahua Wu
AVAshok R. Venkitaraman
Ashok R. Venkitaraman
The anaphase-promoting complex (APC/C), a ubiquitin ligase regulating mitotic progression, is a target for spindle assembly checkpoint. UBE2S, an ubiquitin-conjugating enzyme, is identified as a novel factor that elongates ubiquitin chains and promotes APC/C substrate degradation following release from the spindle assembly checkpoint. The anaphase-promoting complex (APC/C), a ubiquitin ligase, is the target of the spindle-assembly checkpoint (SAC), and it ubiquitylates protein substrates whose degradation regulates progress through mitosis1,2,3. The identity of the ubiquitin-conjugating (E2) enzymes that work with the APC/C is unclear. In an RNA interference (RNAi) screen for factors that modify release from drug-induced SAC activation, we identified the E2 enzyme UBE2S as an APC/C auxiliary factor that promotes mitotic exit. UBE2S is dispensable in a normal mitosis, but its depletion prolongs drug-induced mitotic arrest and suppresses mitotic slippage. In vitro, UBE2S elongates ubiquitin chains initiated by the E2 enzymes UBCH10 and UBCH5, enhancing the degradation of APC/C substrates by the proteasome. Indeed, following release from SAC-induced mitotic arrest, UBE2S-depleted cells neither degrade crucial APC/C substrates, nor silence this checkpoint, whereas bypassing the SAC through BUBR1 depletion or Aurora-B inhibition negates the requirement for UBE2S. Thus, UBE2S functions with the APC/C in a two-step mechanism to control substrate ubiquitylation that is essential for mitotic exit after prolonged SAC activation, providing a new model for APC/C function in human cells.

1 June 2017 in Cell Reports
Verified
Journal Article
Open access
LGLilia Gheghiani
Lilia Gheghiani
DLDAMARYS LOEW
DAMARYS LOEW
BLBérangère Lombard
Bérangère Lombard
JMJörg Mansfeld
Jörg Mansfeld
OGOlivier Gavet
Olivier Gavet
Commitment to mitosis must be tightly coordinated with DNA replication to preserve genome integrity. While we have previously established that the timely activation of CyclinB1-Cdk1 in late G2 triggers mitotic entry, the upstream regulatory mechanisms remain unclear. Here, we report that Polo-like kinase 1 (Plk1) is required for entry into mitosis during an unperturbed cell cycle and is rapidly activated shortly before CyclinB1-Cdk1. We determine that Plk1 associates with the Cdc25C1 phosphatase and induces its phosphorylation before mitotic entry. Plk1-dependent Cdc25C1 phosphosites are sufficient to promote mitotic entry, even when Plk1 activity is inhibited. Furthermore, we find that activation of Plk1 during G2 relies on CyclinA2-Cdk activity levels. Our findings thus elucidate a critical role for Plk1 in CyclinB1-Cdk1 activation and mitotic entry and outline how CyclinA2-Cdk, an S-promoting factor, poises cells for commitment to mitosis.